Santagata Davide: Timely Removal of Retrievable IVC Filters May Reduce VTE Recurrence and Mortality
Santagata Davide, Resident in Internal Medicine at University of Insubria, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Research and Practice in Thrombosis and Haemostasis (RPTH), adding:
“Pleased to share our new publication in Research and Practice in Thrombosis and Haemostasis:
‘Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry.’
In this RIETE Registry analysis of 1,186 patients with VTE receiving retrievable IVC filters, filter retention was associated with worse outcomes compared with filter removal.
Key findings:
- Higher VTE recurrence with retained filters: 7.5 percent versus 1.8 percent
- Recurrences were mainly driven by DVT.
- Filter removal was associated with lower adjusted risk of VTE recurrence
- All-cause mortality was higher in patients with retained filters: 17.0 percent versus 6.3 percent
- Major bleeding remained infrequent and was not significantly different between groups.
Clinical message: retrievable IVC filters require structured follow-up and timely removal whenever clinically feasible.
Grateful to Omri Cohen, Manuel Monreal, the RIETE investigators, and all co-authors for the collaboration.
The accompanying image was AI-generated – with supervision – to present the study on LinkedIn.”
Title: Outcomes in Venous Thromboembolism with Retained versus Removed Inferior Vena Cava Filters: An Analysis from the RIETE Registry
Authors: Omri Cohen, Davide Santagata, Gili Kenet, Juan José López-Núñez, My Hanh Bui, Andris Skride, Patricia López-Miguel, Raimundo Tirado, Fernando Arméstar, Manuel Monreal

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?
-
Nov 8, 2026, 17:36Paschalis Evangelidis: The Multifactorial Nature of Cardiovascular Risk in People With Hemophilia
-
Nov 8, 2026, 17:32Evangelos Panagiotopoulos: Apixaban Reduces Stroke and Major Bleeding Risk in Secondary Stroke Prevention
-
Nov 8, 2026, 17:27Danny Gaskin: Applications Open for the BBTS Specialist Certificate in Clinical Transfusion Practice
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026